Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DU26FENWR
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,881
Award facts
- Contract value 100% obligated
- $4,880.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $4,880.68 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on October 27, 2025, with an ultimate completion date of October 30, 2025, is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The PPV-G GEN V represents a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors capable of supplying comprehensive pharmaceutical products and medical consumables to support Department of Defense healthcare operations globally. No set-aside designation was utilized for this delivery order, demonstrating the contractor's competitive capability in unrestricted federal procurement.
DMS Pharmaceutical Group maintains a broad product portfolio encompassing branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals including oncology treatments, immunosuppressants, emergency medications, and surgical products. The company's base IDC under PPV-G GEN V, valued at $499,999,999 with a completion date of December 31, 2036, provides the contractual vehicle for issuing firm fixed-price delivery orders to fulfill recurring pharmaceutical and medical supply requirements across military healthcare facilities worldwide. The contractor's established performance on numerous delivery orders issued by the DLA's Medical Supply Chain division demonstrates its capability to serve as a critical supplier within the federal military medical system's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DU26FENWR?
SPE2DU26FENWR was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DU26FENWR worth?
The government has obligated $4,881 on SPE2DU26FENWR.
Is contract SPE2DU26FENWR an order under another contract?
Yes. SPE2DU26FENWR is a delivery order under SPE2DU25D9418, an indefinite delivery contract.
Was contract SPE2DU26FENWR competed?
The extent of competition for SPE2DU26FENWR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award